The Innate Immune System and Inflammatory Bowel Disease
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 400
- Locations
- 1
- Primary Endpoint
- gene expression patterns in mucosal biopsies
Study Overview
Brief Summary
The study includes individuals with ulcerative colitis, Crohn's disease and healthy controls. The purpose of this study is to examine the innate immune system (IIS) by exposing peripheral blood monocytes to various ligands relevant for stimulation of the IIS and study the immune response. Colonic mucosal samples are examined to find gene expression patterns which may distinguish the two forms of disease from each other and from healthy controls.
The hypothesis is that the innate immune system has responses unique for the disease states, and that the diseases may be differentiated by examination of gene expression patterns in mucosal biopsies.
Study Design
- Study Type
- Observational
- Observational Model
- Case Control
- Time Perspective
- Cross Sectional
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Presence of ulcerative colitis
- •Presence of Crohn's disease
- •Healthy (no sign of inflammatory bowel disease)
Exclusion Criteria
- •Anticoagulation
- •Cardiac valvular disease
- •Intravascular prosthesis
- •Coagulation disorders
- •Gastrointestinal malignancy
Outcomes
Primary Outcomes
gene expression patterns in mucosal biopsies
Time Frame: 2 years
Secondary Outcomes
No secondary outcomes reported
